GENE EXPRESSION IN AXOTOMIZED RETINAL GANGLION CELLS
GENE EXPRESSION IN AXOTOMIZED RETINAL GANGLION CELLS
批准号:
2710767
负责人:
Leonard A Levin
金额:
$8.92万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-08-01 至 1999-07-31
中文摘要
视网膜神经节细胞的死亡是视网膜病变的最终共同途径。
几乎所有的视神经疾病,包括前部缺血性
视神经病变、视神经炎和压迫性视神经病变。
尽管有大量的研究探讨了缺氧的直接影响,
兴奋性毒素等对视网膜神经节细胞的损伤,
这些轴突损伤的细胞是大多数视神经病变的基础,
更不清楚的是。促进神经节再生的尝试
轴突切断后的细胞轴突以完整的神经节细胞索马为前提;只有通过
防止神经节细胞死亡,
战略将取得成功。因此,本提案的总体目标是
使用最近开发的技术,以更好地了解亚细胞
轴突损伤导致视网膜神经节细胞死亡的潜在事件。
目前的假设是,视网膜神经节细胞的轴突切断导致
这些基因的表达开启了细胞死亡的程序,
基因及其产物可以被表征。长期目标是
调节这些基因或它们的产物,因此可以拯救
视神经受损时,视网膜神经节细胞。
第一个具体的目标是确定差异表达的基因,
轴突切断的视网膜神经节细胞。消减拷贝DNA(cDNA)文库
将由从轴突切断和
对照大鼠视网膜。候选cDNA将用北方引物进行筛选。
印迹或使用RNA探针的核糖核酸酶保护测定。第二
具体目标是研究组织,物种和发育表达
已识别的基因。基因序列将被用来寻找
与细胞死亡相关的其他基因的同源性。第三特定
目的是表达基因的蛋白质产物,并确定其
定位和可能的功能。
该项目与健康有关的是影响儿童健康的疾病,
前和球后视神经。虽然这些疾病直接
损伤视神经内所含的轴突,
视觉反映了视网膜内神经节细胞的死亡。
了解神经节细胞对
轴突损伤将允许开发用于这些疾病的疗法。的
有机会接受分子生物学的正式培训,
这项研究计划也将进一步申请人的目标,成为
独立调查员
英文摘要
Death of retinal ganglion cells is the final common pathway underlying
virtually all diseases of the optic nerve, including anterior ischemic
optic neuropathy, optic neuritis, and compressive optic neuropathy.
Despite a wealth of studies examining the direct effect of hypoxia,
excitotoxins, and other injuries on retinal ganglion cells, the effect on
these cells of axonal injury, which underlies most optic neuropathies, is
far less clearly understood. Attempts to promote regeneration of ganglion
cell axons after axotomy presupposes an intact ganglion cell soma; only by
preventing ganglion cell death can it be expected that regenerative
strategies will succeed. Therefore the overall goal of this proposal is to
use recently developed techniques to better understand the subcellular
events underlying death of retinal ganglion cells due to axonal injury.
The working hypothesis is that axotomy of retinal ganglion cells causes
expression of genes that turn on a program for cell death, and that these
genes and their products can be characterized. The long-term goal is to
modulate these genes or their products and therefore allow rescue of
retinal ganglion cells when the optic nerve is injured.
The first specific aim is to identify genes differentially expressed in
axotomized retinal ganglion cells. A subtracted copy DNA (cDNA) library
will be made from messenger RNA (mRNA) extracted from axotomized and
control rat retinas. Candidate cDNAs will be screened with Northern
blotting or ribonuclease protection assay using RNA probes. The second
specific aim is to study the tissue, species, and developmental expression
of the identified genes. Gene sequences will be used to look for
homologies to other genes associated with cell death. The third specific
aim is to express the protein products of the genes and determine their
localization and possible function.
The health-relatedness of this project is to diseases affecting the
anterior and retrobulbar optic nerve. While these disorders directly
damage axons contained within the optic nerve, the irreversible loss of
vision reflects the death of ganglion cells contained within the retina.
Understanding the subcellular nature of the ganglion cell response to
axonal injury will allow development of therapies for these diseases. The
opportunity to receive formal training in molecular biology and carry out
this research program will also further the applicant's goal of becoming
an independent investigator.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Expression of ceruloplasmin in the retina: induction after optic nerve crush.
视网膜中铜蓝蛋白的表达:视神经挤压后的诱导。
DOI:
--
发表时间:
1998
期刊:
Investigative ophthalmology & visual science.
影响因子:
--
作者:
[Levin,LA, Geszvain,KM]
通讯作者:
Geszvain,KM
Identification of the bcl-2 family of genes in the rat retina.
大鼠视网膜中 bcl-2 基因家族的鉴定。
DOI:
--
发表时间:
1997
期刊:
Investigative ophthalmology & visual science.
影响因子:
--
作者:
[Levin,LA, Schlamp,CL, Spieldoch,RL, Geszvain,KM, Nickells,RW]
通讯作者:
Nickells,RW
Effect of lipid peroxidation inhibition on retinal ganglion cell death.
脂质过氧化抑制对视网膜神经节细胞死亡的影响。
DOI:
--
发表时间:
1996
期刊:
Investigative ophthalmology & visual science
影响因子:
4.4
作者:
[Levin,LA, Clark,JA, Johns,LK]
通讯作者:
Johns,LK
Development of redox-active therapies for ischemic optic neuropathy
-
批准号:8975773
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2014
-
负责人:Leonard A Levin
-
依托单位:
Development of redox-active therapies for ischemic optic neuropathy
-
批准号:8809877
-
项目类别:
-
资助金额:$19.13万
-
财政年份:2014
-
负责人:Leonard A Levin
-
依托单位:
Novel Mitochondrial Targeted Neuroprotectants for Glaucoma
-
批准号:7917762
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2009
-
负责人:Leonard A Levin
-
依托单位:
Novel Mitochondrial Targeted Neuroprotectants for Glaucoma
-
批准号:7351810
-
项目类别:
-
资助金额:$20.37万
-
财政年份:2007
-
负责人:Leonard A Levin
-
依托单位:
Novel Mitochondrial Targeted Neuroprotectants for Glaucoma
-
批准号:7189148
-
项目类别:
-
资助金额:$18.08万
-
财政年份:2007
-
负责人:Leonard A Levin
-
依托单位:
GENE EXPRESSION IN AXOTOMIZED RETINAL GANGLION CELLS
-
批准号:6195717
-
项目类别:
-
资助金额:$28.25万
-
财政年份:2000
-
负责人:Leonard A Levin
-
依托单位:
GENE EXPRESSION IN AXOTOMIZED RETINAL GANGLION CELLS
-
批准号:6635669
-
项目类别:
-
资助金额:$28.8万
-
财政年份:2000
-
负责人:Leonard A Levin
-
依托单位:
GENE EXPRESSION IN AXOTOMIZED RETINAL GANGLION CELLS
-
批准号:6950900
-
项目类别:
-
资助金额:$7.39万
-
财政年份:2000
-
负责人:Leonard A Levin
-
依托单位:
GENE EXPRESSION IN AXOTOMIZED RETINAL GANGLION CELLS
-
批准号:6518620
-
项目类别:
-
资助金额:$28.8万
-
财政年份:2000
-
负责人:Leonard A Levin
-
依托单位:
GENE EXPRESSION IN AXOTOMIZED RETINAL GANGLION CELLS
-
批准号:6384792
-
项目类别:
-
资助金额:$28.8万
-
财政年份:2000
-
负责人:Leonard A Levin
-
依托单位:
GENE EXPRESSION IN AXOTOMIZED RETINAL GANGLION CELLS
-
批准号:2157848
-
项目类别:
-
资助金额:$7.91万
-
财政年份:1994
-
负责人:Leonard A Levin
-
依托单位:
GENE EXPRESSION IN AXOTOMIZED RETINAL GANGLION CELLS
-
批准号:2157850
-
项目类别:
-
资助金额:$9.0万
-
财政年份:1994
-
负责人:Leonard A Levin
-
依托单位:
GENE EXPRESSION IN AXOTOMIZED RETINAL GANGLION CELLS
-
批准号:2157849
-
项目类别:
-
资助金额:$7.92万
-
财政年份:1994
-
负责人:Leonard A Levin
-
依托单位:
GENE EXPRESSION IN AXOTOMIZED RETINAL GANGLION CELLS
-
批准号:2459044
-
项目类别:
-
资助金额:$9.0万
-
财政年份:1994
-
负责人:Leonard A Levin
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: